Pick the winner designs in phase II cancer clinical trials

被引:11
|
作者
Mandrekar, Sumithra J. [1 ]
Sargent, Daniel J. [1 ]
机构
[1] Mayo Clin, Mayo Clin Canc Ctr, Div Biostat, Rochester, MN 55905 USA
关键词
D O I
10.1097/01243894-200601000-00003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
  • [1] Play the winner for phase II/III clinical trials
    Yao, Q
    Wei, LJ
    [J]. STATISTICS IN MEDICINE, 1996, 15 (21-22) : 2413 - 2423
  • [2] A Bayesian pick-the-winner design in a randomized phase II clinical trial
    Chen, Dung-Tsa
    Huang, Po-Yu
    Lin, Hui-Yi
    Chiappori, Alberto A.
    Gabrilovich, Dmitry I.
    Haura, Eric B.
    Antonia, Scott J.
    Gray, Jhanelle E.
    [J]. ONCOTARGET, 2017, 8 (51) : 88376 - 88385
  • [3] Admissible two-stage designs for phase II cancer clinical trials
    Jung, SH
    Lee, T
    Kim, KM
    George, SL
    [J]. CONTROLLED CLINICAL TRIALS, 2003, 24 : 61S - 61S
  • [4] Admissible two-stage designs for phase II cancer clinical trials
    Jung, SH
    Lee, T
    Kim, K
    George, SL
    [J]. STATISTICS IN MEDICINE, 2004, 23 (04) : 561 - 569
  • [5] Multistage designs for phase II clinical trials: Statistical issues in cancer research
    Kramar, A
    Potvin, D
    Hill, C
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (08) : 1317 - 1320
  • [6] Bayesian Mixture Designs for Phase II Clinical Trials
    Mao, Lian
    Zhang, Ying
    Singh, Jagbir
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2010, 2 (02): : 260 - 269
  • [7] Optimal flexible designs in phase II clinical trials
    Chen, TT
    Ng, TH
    [J]. STATISTICS IN MEDICINE, 1998, 17 (20) : 2301 - 2312
  • [8] Effectiveness of adaptive designs for phase II cancer trials
    Fors Lopez, Martha
    Dupuy, Jean-Francois
    Viada Gonzalez, Carmen
    [J]. CONTEMPORARY CLINICAL TRIALS, 2012, 33 (01) : 223 - 227
  • [9] Randomized phase II designs in cancer clinical trials: Current status and future directions
    Lee, JJ
    Feng, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4450 - 4457
  • [10] On the Time to Conclusion of Phase II Cancer Clinical Trials and Its Application in Trial Designs
    Lu, Ying
    Fan, Sheng-Hua Kelly
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2012, 4 (04): : 324 - 335